$JOBY

Cerberus Announces Agreement to Sell Resonant Sciences to Joby Aviation

Cerberus announced an agreement to sell Resonant Sciences to Joby Aviation. After closing, Resonant will operate as Joby’s dedicated defense business under the Resonant Sciences name. The deal is expected to close in the first half of 2027, subject to customary conditions and regulatory reviews.

Original reporting
Published Aug 11, 2026, 6:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 10:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cerberus Announces Agreement to Sell Resonant Sciences to Joby Aviation — source image
Decision brief

The 30-second read

$JOBYBullishMed
01

Why it matters

This is a corporate control transaction with a defined expected closing window (1H 2027) and regulatory review as a key gating item. The main tradable implications are deal certainty, potential valuation re-rating, and future defense segment strategy for Joby.

02

Market read

A defense-tech M&A agreement links Resonant’s RF/sensing capabilities to Joby’s defense strategy, with closing targeted for 1H 2027.

03

What to watch

Traders should watch for any disclosed financing structure, regulatory review scope, and whether Resonant’s customer contracts transfer cleanly post-close.

Relevance 8/10Novelty 6/10Timing: expected close in 1H 2027, subject to customary regulatory reviews

Background

Cerberus (via its supply chain platform) has agreed to sell Resonant Sciences to Joby Aviation; Resonant will continue operating under its name as Joby’s dedicated defense business.

Company-level read

Ticker impact

$JOBYBullishMedium confidence
Context

Joby will receive Resonant Sciences as its dedicated defense business, with closing expected in 1H 2027 subject to regulatory reviews.

Expected impact

Near-term sentiment likely positive on deal framing, with volatility around regulatory and closing milestones.

Evidence & confidence

The article discloses a specific M&A transaction structure and timing window, but provides no financial terms or guidance to quantify impact.

Market effects

Could signal consolidation in defense RF and sensing systems, potentially affecting competitive positioning and procurement expectations for defense tech suppliers.

No specific regional impact described beyond U.S. national security customer focus.

Defense technology demand and allied security resilience themes may resonate with broader defense industrial supply chains.

Counterpoint

Without deal economics, the market may discount the strategic story and focus on regulatory and integration risk, limiting upside follow-through.

Key entities

  • Joby Aviation

    Will make Resonant Sciences its dedicated defense business after closing, with Resonant continuing under its existing name.

  • Resonant Sciences

    Agreed to be sold; will continue operating under its name as part of Joby’s defense business post-close.

  • Cerberus

    Alternative investment firm that announces the agreement to sell Resonant Sciences.

Related articles

$JOBYMed

Stock Market Today, Aug. 11: Joby Aviation Falls 4% After $500M Defense Acquisition and Stock Sale Plan

Joby Aviation (JOBY) fell about 4% to around $8.43 after announcing a $500 million acquisition of Resonant Sciences and a planned $750 million at-the-market stock sale. The company said the deal combines aircraft and propulsion tech with Resonant’s RF sensing and low-observability systems. Investors are watching funding for certification, manufacturing, and launch.

$JOBYMedAI 9/10

Joby to buy Resonant Sciences, establish defense business in $500 million deal

Joby Aviation agreed to buy Resonant Sciences to form a dedicated defense business in a $500 million deal, with about $450 million in cash and $50 million in Joby common stock, subject to regulatory approval and expected to close in H1 2027. Resonant will keep its name and leadership. Joby also entered an equity distribution agreement to sell up to $750 million of common stock.

$JOBYMedAI 9/10

Santa Cruz's Joby Aviation Buys Ohio Defense Firm for $500 Million

Joby Aviation will buy Ohio defense tech firm Resonant Sciences for about $500 million, funded with about $450 million cash and $50 million common stock, with closing expected in the first half of 2027, according to Reuters. Resonant’s radio-frequency and mission systems will form Joby’s defense unit. Joby shares fell about 6.5% premarket. Joby also launched a $750 million at-the-market equity program.